Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial.
Lambertini M, Agbor-Tarh D, Metzger-Filho O, Ponde NF, Poggio F, Hilbers FS, Korde LA, Chumsri S, Werner O, Del Mastro L, Caparica R, Moebus V, Moreno-Aspitia A, Piccart MJ, de Azambuja E. Lambertini M, et al. Among authors: ponde nf. ESMO Open. 2020 Nov;5(6):e000979. doi: 10.1136/esmoopen-2020-000979. ESMO Open. 2020. PMID: 33154022 Free PMC article. Clinical Trial.
Twenty years of anti-HER2 therapy-associated cardiotoxicity.
Pondé NF, Lambertini M, de Azambuja E. Pondé NF, et al. ESMO Open. 2016 Jul 21;1(4):e000073. doi: 10.1136/esmoopen-2016-000073. eCollection 2016. ESMO Open. 2016. PMID: 27843627 Free PMC article. Review.
Adjuvant trastuzumab: a 10-year overview of its benefit.
Lambertini M, Pondé NF, Solinas C, de Azambuja E. Lambertini M, et al. Among authors: ponde nf. Expert Rev Anticancer Ther. 2017 Jan;17(1):61-74. doi: 10.1080/14737140.2017.1264876. Epub 2016 Dec 5. Expert Rev Anticancer Ther. 2017. PMID: 27883296 Review.
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber RD, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart M. Pondé N, et al. Breast Cancer Res Treat. 2021 Jan;185(1):107-116. doi: 10.1007/s10549-020-05915-9. Epub 2020 Sep 19. Breast Cancer Res Treat. 2021. PMID: 32951084 Free PMC article. Clinical Trial.
53 results